Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jan 1, 2018	Dec 31, 2016
Chemical Pharmaceutical Technology	3.77B	4.01B	-	-	-
Chemical Pharmaceutical Technology Growth	-6.04%	-	-	-	-
Pharmaceutical Commercial	58.17B	54.60B	-	-	-
Pharmaceutical Commercial Growth	6.53%	-	-	-	-
Modern Chinese Medicine	7.52B	8.04B	-	-	-
Modern Chinese Medicine Growth	-6.46%	-	-	-	-
Others	6.48B	7.03B	865.40M	820.21M	665.25M
Others Growth	-7.84%	712.23%	5.51%	23.29%	33.45%
Natural Beverage	9.73B	9.75B	11.17B	10.53B	10.91B
Natural Beverage Growth	-0.16%	-12.72%	6.09%	-3.56%	37.11%
offset of business segment	-8.01B	-8.44B	-9.36B	-8.75B	-6.32B
Grand commercial	-	-	61.70B	57.51B	52.61B
Grand commercial Growth	-	-	7.29%	9.30%	6.20%
Four traditional Chinese medicine	-	-	11.14B	10.69B	11.14B
Four traditional Chinese medicine Growth	-	-	4.22%	-4.05%	-17.61%
Total	77.66B	74.99B	75.52B	70.79B	69.01B
Total Growth	3.55%	-0.69%	6.68%	2.57%	11.90%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jan 1, 2018	Dec 31, 2016
China	77.36B	74.72B	75.17B	70.76B	68.97B
China Growth	3.54%	-0.60%	6.23%	2.59%	11.91%
Other Countries/Regions	294.31M	275.23M	344.30M	27.52M	42.82M
Other Countries/Regions Growth	6.93%	-20.06%	1151.28%	-35.75%	7.00%
Total	77.66B	74.99B	75.52B	70.79B	69.01B
Total Growth	3.55%	-0.69%	6.68%	2.57%	11.90%

Source: S&P Global Market Intelligence.